Filter
2423
Filtered Results: 2423
Text search:
drug-resistance
infections
Featured
Recommendations
275
New Publications
658
Language
Document type
No document type
1415
Guidelines
376
Studies & Reports
354
Manuals
99
Strategic & Response Plan
74
Fact sheets
37
Training Material
35
Situation Updates
14
Infographics
11
Resource Platforms
3
Brochures
2
Online Courses
2
Videos
1
Countries / Regions
India
137
Kenya
72
South Africa
70
Western and Central Europe
67
Global
58
Ethiopia
56
Africa
45
Uganda
44
Eastern Europe
42
Nepal
41
Tanzania
41
Nigeria
37
Zambia
35
Liberia
33
Sierra Leone
30
Malawi
30
Latin America and the Carribbean
28
Rwanda
26
Ghana
24
Namibia
24
Myanmar / Burma
24
Philippines
23
Bangladesh
23
Asia
22
Cambodia
21
South–East Asia Region
21
Zimbabwe
18
Lesotho
17
Ukraine
16
Russia
15
Senegal
14
Indonesia
13
Mozambique
12
Congo, Democratic Republic of
11
Cameroon
11
Botswana
10
West and Central Africa
10
East and Southern Africa
9
Burkina Faso
8
Eswatini/ Swaziland
8
Middle East and North Africa
8
Albania
8
Pakistan
7
Thailand
7
USA
6
Haiti
6
Syria
6
Argentina
6
Colombia
6
Eastern Europe and Central Asia
6
Venezuela
6
Guinea
5
Georgia
5
Germany
4
China
4
Sudan
4
Benin
4
Brazil
4
Western Pacific Region
4
Tajikistan
4
Somalia
3
South Sudan
3
Iraq
3
Jordan
3
Lebanon
3
Central African Republic
3
Peru
3
North Macedonia
3
Bhutan
3
Laos
3
Iran
3
Vietnam
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Afghanistan
2
Papua New Guinea
2
El Salvador
2
Madagascar
2
Mexico
2
Sri Lanka
2
Yemen
2
Paraguay
2
Armenia
2
Southern Africa
2
Timor Leste/ East Timor
2
Estonia
2
Moldova
2
Gabon
2
Uruguay
2
Tunisia
2
Guinea-Bissau
1
Niger
1
Turkey
1
Egypt
1
Gambia
1
Switzerland
1
Serbia
1
Honduras
1
Ecuador
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Nicaragua
1
Fiji
1
Congo-Brazzaville
1
Canada
1
Qatar
1
North America
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
854
Clinical Guidelines
283
Public Health
104
Women & Child Health
76
Key Resources
48
Capacity Building
34
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
TB
440
HIV
327
AMR
316
NTDs
90
COVID-19
81
Rapid Response
58
Mental Health
55
Pharmacy
54
Caregiver
43
Planetary Health
42
Ebola
32
Refugee
27
Global Health Education
27
NCDs
20
Polio
15
Conflict
13
Cholera
12
Health Financing Toolbox
11
Disability
7
Natural Hazards
7
Zika
4
Specific Hazards
3
Social Ethics
1
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding, ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica...
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t...
